Price movement over the last 24 hours
Asri Karya Lestari Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Asri Karya Lestari Tbk. trades at Rp200 (market cap 1.29T, 1.73M 24h volume), while Brigit Biofarmaka Teknologi Tbk. trades at Rp242 (market cap 160.57B, 2.51M 24h volume). The key difference: Asri Karya Lestari Tbk. is far larger — about 8× Brigit Biofarmaka Teknologi Tbk.'s market cap, and Brigit Biofarmaka Teknologi Tbk. is more actively traded (2.51M versus 1.73M). Which is the better fit depends on your goals.
| ASLI | OBAT | |
|---|---|---|
Market Cap | 1.29T | 160.57B |
Volume | 1.73M | 2.51M |
Lot | 17.29K | 25.09K |
Turnover | 349.74M | 636.74M |
Average Price | 202.26 | 253.78 |
Value | 349.74M | 636.74M |
Indicative Equilibrium Price | 200 | 242 |
Indicative Equilibrium Volume | 1.01K | 146 |
Trailing returns across standard periods
Latest headlines on both assets
PT Asri Karya Lestari Tbk (‘the Entity’) was established as a limited liability company based on deed No. 05 on December 20, 2008 before Notary Syanti Hardiyanti, SH in Jakarta. The entity started its commercial operations in 2009
Read more on ASLI →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →